{"_id":"token-622519","name":"Re Protocol reUSDe (mezzanine reinsurance tranche)","ticker":"reUSDe","pillar":"Fixed Income","type":"Reinsurance Yield Token","category":"Reinsurance","description":"Receipt token of Re Protocol’s mezzanine tranche: absorbs reinsurance claims after premiums and Re’s junior capital, before reUSD — higher yield, higher loss risk. Backed by Principal-at-Risk Notes of Cover Reinsurance SPC (Cayman, CIMA); no direct legal claim on the contracts. Target: risk-free rate + 8.5 %.","apy":"~11.8% (Re app, 2026-10-28)","risk":"High (first-loss after junior capital)","minInvestment":"None","issuer":"Re Protocol (Resilience (BVI) Ltd; underwriting Cover Reinsurance SPC, Cayman, CIMA)","yieldSource":"Reinsurance premiums + yield on collateral (mezzanine tranche)","maturity":null,"term":null,"liquidity":"Redeem with Re in quarterly windows only, filled pro rata, paid in sUSDe; KYC checked at claim","aum":"$20.0M","network":"Ethereum / Berachain","country":"Cayman Islands / BVI","custody":"Self-custody","howToBuy":"Mint at app.re.xyz after KYC (USDe or sUSDe); fixed-rate exposure via the Pendle PT-reUSDe market","rating":null,"kyc":"Required to mint and redeem (non-US persons only)","networkFee":null,"networkFeeUsd":null,"investUrl":"https://app.re.xyz","source":"https://docs.re.xyz/products/about-reusde.md","lastVerified":"2026-10-28","featured":false,"apyPct":11.8,"apyPctLow":11.8,"apyPctHigh":11.8,"apyKind":"variable","minInvestmentUsd":0,"custodyType":"self","access":{"kycMint":"required","kycSecondary":"unknown","kycRedeem":"required","accreditedOnly":false,"whitelistRequired":false},"verified":"curated","isin":null,"underlyingSymbol":null,"underlyingIsin":null,"lifecycle":"live","maturityDate":null,"contract":"0xdDC0f880ff6e4e22E4B74632fBb43Ce4DF6cCC5a","targetArea":[],"areas":[],"_links":{"page":"https://tokenbank.world/token/reUSDe","all":"https://tokenbank.world/api/tokens"},"_disclaimer":"Sourced figures; yields are variable and not guaranteed. Target/Area describe who the issuer aims the product at and where. They are not an eligibility check — who may buy is set by the issuer. Not investment advice. Verify the source before relying on any figure."}